Taro Pharmaceutical
TARO
#5055
Rank
NZ$2.79 B
Marketcap
NZ$74.38
Share price
0.00%
Change (1 day)
10.15%
Change (1 year)

Market capitalization of Taro Pharmaceutical (TARO)

Last known market cap: NZ$2.79 Billion

On August 23, 2024 Taro Pharmaceutical had a market cap of NZ$2.79 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Taro Pharmaceutical from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$2.86 B15.33%
2023NZ$2.48 B44.44%
2022NZ$1.71 B-37.65%
2021NZ$2.75 B-29.17%
2020NZ$3.89 B-22.63%
2019NZ$5.03 B2.2%
2018NZ$4.92 B-16.73%
2017NZ$5.91 B-5.18%
2016NZ$6.23 B-35.53%
2015NZ$9.67 B19.4%
2014NZ$8.10 B50.36%
2013NZ$5.38 B105.56%
2012NZ$2.62 B55.7%
2011NZ$1.68 B108.05%
2010NZ$0.80 B68.62%
2009NZ$0.47 B-7.74%
2008NZ$0.52 B32.01%
2007NZ$0.39 B-5.45%
2006NZ$0.41 B-30.42%
2005NZ$0.59 B-56.95%
2004NZ$1.39 B-51.6%
2003NZ$2.87 B39.19%
2002NZ$2.06 B-18.39%
2001NZ$2.53 B564.81%
2000NZ$0.38 B154.1%
1999NZ$0.14 B210.25%
1998NZ$48.28 M2.96%
1997NZ$46.89 M4.18%
1996NZ$45.01 M

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
NZ$256.18 B 9,063.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$431.15 B 15,322.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$842.14 B 30,024.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.52 B 1,921.76%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$169.15 B 5,950.65%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$438.96 B 15,601.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland